✦ LIBER ✦

Continuous infusion idarubicin and oral busulfan as conditioning for patients with acute myeloid leukemia aged over 60 years undergoing autologous stem cell transplantation

✍ Scribed by Ferrara, F; Palmieri, S; Annunziata, M; Viola, A; Pocali, B; Califano, C; D'Arco, A M; Mele, G

Book ID: 110014271
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 108 KB
Volume: 34
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1704611

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Continuous infusion idarubicin and intra

Continuous infusion idarubicin and intravenous busulphan as conditioning regimen to autologous stem cell transplantation for patients with acute myeloid leukaemia

✍ Felicetto Ferrara; Giuseppina Mele; Salvatore Palmieri; Mariangela Pedata; Carol 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

## Abstract The current study aimed to evaluate the efficacy and toxicity of a combination of intravenous (iv) busulfan (Bu) and continuous infusion Idarubicin (IDA) as a conditioning regimen to autologous haematopoietic stem cell transplantation (ASCT) in patients with acute myeloid leukaemia (AML

Autologous stem cell transplantation for

Autologous stem cell transplantation for elderly patients with acute myeloid leukaemia conditioned with continuous infusion idarubicin and busulphan

✍ Felicetto Ferrara; Salvatore Palmieri; Mariangela Pedata; Assunta Viola; Tiziana 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

## Abstract Different studies have suggested the potential utility of autologous stem cell transplantation (ASCT) in acute myeloid leukaemia (AML) of the elderly with encouraging results in selected patients. However, while the introduction of peripheral blood stem cells (PBSC) has consistently red